What Are the Side Effects of Stopping Wegovy?

Why stopping feels different from other medicines stopping

Semaglutide does not create physical dependence, and there is no recognised withdrawal syndrome in the clinical literature. That distinction matters. What people do experience is the reversal of the medicine's effects: appetite returns because GLP-1 receptor activity fades, gastric emptying speeds back up, and the hormonal signals that made smaller portions feel satisfying are no longer amplified. It can feel abrupt even when it is not, because those effects had become the new normal.

For many people, nausea and other GI effects that were present during dose increases simply stop, that part of stopping is often a relief. The NHS notes that gut-related effects are among the most common during Wegovy treatment, and they do tend to ease once the medicine is out of your system. You can read more about how those effects behave during treatment on our page covering common Wegovy side effects.

What is less comfortable for some people is the appetite resurgence. Clinical follow-up data consistently shows that weight regain begins within weeks to months of stopping, and in trials participants regained a substantial proportion of their lost weight within a year or two without continued treatment. That is a biological response, not a failure of willpower. Understanding it is part of making an informed decision.

Weight regain and appetite changes after stopping

The evidence here is reasonably clear. The STEP 4 trial, published in JAMA, followed people who stopped semaglutide after 20 weeks and found significant weight regain over the subsequent year compared with those who continued. Trial participants who stopped did not regain all the weight immediately, but the trajectory was consistent. The body's set-point mechanisms (the ones that Wegovy was partly working against) reassert themselves.

Hunger can feel more intense than it did before treatment began, at least initially. Some people describe cravings for calorie-dense foods returning sharply. This is not universal, and the degree varies, but it is a known pattern documented in post-treatment readjustment accounts and in clinical literature. The NHS's own guidance on semaglutide acknowledges that weight management medicines work alongside lifestyle changes, and that stopping the medicine means the lifestyle component carries more of the load.

If you are considering stopping because of side effects rather than by choice, it is worth exploring whether a dose reduction or a pause is more appropriate than a full stop. A prescriber can help weigh that up. Our clinical team is available through our support line seven days a week for exactly these conversations.

Factors that should shape your decision to stop

This is the core of what a SK3 decision-led page is for: not just listing what might happen, but helping you think through why and when stopping makes sense.

There are good reasons to stop: you have reached a stable weight and want to manage it through lifestyle alone; you are planning to conceive (semaglutide is not recommended during pregnancy or when trying to conceive, and a wash-out period is advised before attempting conception, your prescriber will confirm the timing); side effects are significantly affecting your quality of life; or a new health condition or medicine interaction has changed your clinical picture.

There are also reasons to reconsider stopping that are worth naming: temporary side effects that would likely settle, short-term cost pressure, or a sense that the medicine is no longer working at the current dose when a titration review might help. Our page on stopping versus continuing goes further into the clinical reasoning, and our prescribers discuss this openly during every review. For context on how Wegovy works and what it is licensed for in the UK, the Wegovy overview is a good starting point.

The right route is never a unilateral decision made between you and an internet search. The prescriber who has your records is best placed to advise, and at nume, that clinical re-review happens before every repeat order, which means the conversation about whether to continue is built into the process.

When to seek medical help after stopping Wegovy

Most people who stop Wegovy experience nothing that requires urgent medical attention. Hunger returning is not a medical emergency. But some symptoms after stopping do warrant prompt attention, and if you want a fuller picture before you reach that point, our pages covering what are the side effects of Wegovy and what are the main side effects of Wegovy set out the clinical detail in one place.

Seek medical help if you experience severe abdominal pain, particularly pain that spreads to your back, with or without vomiting, this can be a sign of pancreatitis, which the MHRA has highlighted as an infrequent but serious risk associated with GLP-1 medicines. The MHRA Drug Safety Update issued in January 2026 specifically flagged acute pancreatitis as a risk to monitor throughout treatment and in the period after stopping.

Also seek help for signs of gallbladder problems (severe pain in the upper right abdomen, fever, jaundice), symptoms of dehydration if GI effects persist beyond the first days, or any symptoms you cannot account for and that worry you. Your GP is the right first call. If you want to report a suspected side effect, the Yellow Card scheme accepts reports from patients directly, it is one of the most useful tools the MHRA has for tracking real-world medicine safety.

If you are thinking about what treatment might look like going forward, whether that means restarting Wegovy, exploring other licensed options, or understanding the full landscape, our treatment overview sets out the options available through a regulated UK prescriber. And if you are at the stage of checking clinical suitability, checking your eligibility is a good place to start.